FluvoxaMINE
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3509 publications
Neuroinflammation as a key target in the treatment of post-stroke depression
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: April 07, 2026
Summary for Patients: Fluvoxamine and Metformin for Fatigue in Patients With Long COVID.
Journal: Annals of internal medicine
Published: March 30, 2026
The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized Trial.
Journal: Annals of internal medicine
Published: March 30, 2026
An update on the pharmacokinetic and pharmacodynamic interactions between antidepressants and antiseizure medications.
Journal: Expert opinion on drug metabolism & toxicology
Published: March 24, 2026
Precision dosing of clozapine: A physiologically based pharmacokinetic/pharmacodynamic model integrating genetic polymorphisms and clinical outcomes.
Journal: Journal of psychopharmacology (Oxford, England)
Published: March 09, 2026
Current options for the treatment of anxiety in adults with autism spectrum disorder.
Journal: Expert review of neurotherapeutics
Published: February 24, 2026
Cardiac Valvular Incompetence Associated With Selective Serotonin Reuptake Inhibitors (SSRIs): A Disproportionality and Risk Factor Analysis From Global Safety Reports.
Journal: Cureus
Published: January 13, 2026
Evaluating the Impact of CYP2D6 Phenotype on Fluvoxamine Pharmacokinetics in Geriatric Patients Using Physiologically Based Pharmacokinetic Modeling.
Journal: Pharmaceutics
Published: January 13, 2026
Prolonged Tardive Dyskinesia Induced by Long-Acting Paliperidone Palmitate in Schizophrenia: A Case Report.
Journal: The American journal of case reports
Published: January 10, 2026
Neuroinflammation as a therapeutic target in post-stroke depression
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: December 28, 2025
Last Updated: 04/28/2026